Ohlin H - Search Results

1

Plasma homocysteine and markers for oxidative stress and inflammation in patients with coronary artery disease--a prospective randomized study of vitamin supplementation.

Jonasson T, Ohlin AK, Gottsäter A, Hultberg B, Ohlin H. Jonasson T, et al. Among authors: ohlin ak, ohlin h. Clin Chem Lab Med. 2005;43(6):628-34. doi: 10.1515/CCLM.2005.108. Clin Chem Lab Med. 2005. PMID: 16006259 Clinical Trial.

2

Renal function exerts only a minor influence on high plasma homocysteine concentrations in patients with acute coronary syndromes.

Jonasson T, Ohlin H, Andersson A, Arnadottir M, Hultberg B. Jonasson T, et al. Among authors: ohlin h. Clin Chem Lab Med. 2002 Feb;40(2):137-42. doi: 10.1515/CCLM.2002.024. Clin Chem Lab Med. 2002. PMID: 11939486

3

Vitamin supplementation normalizes total plasma homocysteine concentration but not plasma homocysteine redox status in patients with acute coronary syndromes and hyperhomocysteinemia.

Andersson A, Jonasson T, Ohlin H, Lindgren A, Hultberg B. Andersson A, et al. Among authors: ohlin h. Clin Chem Lab Med. 2002 Jun;40(6):554-8. doi: 10.1515/CCLM.2002.095. Clin Chem Lab Med. 2002. PMID: 12211647 Clinical Trial.

4

Hyperhomocysteinaemia is not associated with increased levels of asymmetric dimethylarginine in patients with ischaemic heart disease.

Jonasson TF, Hedner T, Hultberg B, Ohlin H. Jonasson TF, et al. Among authors: ohlin h. Eur J Clin Invest. 2003 Jul;33(7):543-9. doi: 10.1046/j.1365-2362.2003.01184.x. Eur J Clin Invest. 2003. PMID: 12814389 Clinical Trial.

5

Lipid peroxidation is not increased in heart failure patients on modern pharmacological therapy.

Tingberg E, Ohlin AK, Gottsäter A, Ohlin H. Tingberg E, et al. Among authors: ohlin ak, ohlin h. Int J Cardiol. 2006 Oct 10;112(3):275-81. doi: 10.1016/j.ijcard.2005.09.004. Epub 2005 Nov 28. Int J Cardiol. 2006. PMID: 16310262 Clinical Trial.

6

Dissociation of the Inflammatory Reaction following PCI for Acute Myocardial Infarction.

Aström-Olsson K, Hedström E, Hultén LM, Wiklund O, Arheden H, Ohlin AK, Gottsäter A, Ohlin H. Aström-Olsson K, et al. Among authors: ohlin ak, ohlin h. J Invasive Cardiol. 2007 Nov;19(11):452-6. J Invasive Cardiol. 2007. PMID: 17986718

7

No increase of plasma malondialdehyde after primary coronary angioplasty for acute myocardial infarction.

Olsson KA, Harnek J, Ohlin AK, Pavlidis N, Thorvinger B, Ohlin H. Olsson KA, et al. Among authors: ohlin ak, ohlin h. Scand Cardiovasc J. 2002 Aug;36(4):237-40. doi: 10.1080/14017430260180409. Scand Cardiovasc J. 2002. PMID: 12201972 Free article. Clinical Trial.

8

Transient release of lipid peroxidation products as a non-invasive marker of successful reperfusion after thrombolysis for myocardial infarction.

Ohlin H, Gustavsson CG, Pantev E, Thorvinger B, Ohlin AK. Ohlin H, et al. Among authors: ohlin ak. Br Heart J. 1995 Mar;73(3):223-6. doi: 10.1136/hrt.73.3.223. Br Heart J. 1995. PMID: 7727180 Free PMC article.

9

Soluble thrombomodulin antigen in plasma is increased in patients with acute myocardial infarction treated with thrombolytic therapy.

Ohlin AK, Morser J, Ohlin H. Ohlin AK, et al. Among authors: ohlin h. Thromb Res. 1996 May 15;82(4):313-22. doi: 10.1016/0049-3848(96)00081-3. Thromb Res. 1996. PMID: 8743727

10

Effect of intravenous nitroglycerin on lipid peroxidation after thrombolytic therapy for acute myocardial infarction.

Ohlin H, Pavlidis N, Ohlin AK. Ohlin H, et al. Among authors: ohlin ak. Am J Cardiol. 1998 Dec 15;82(12):1463-7. doi: 10.1016/s0002-9149(98)00688-2. Am J Cardiol. 1998. PMID: 9874048 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

70 results

Search Page

Filters